Skip to content

A Clinical Study in Patients with Bleeding to Evaluate the Use of Hemoflavin Gel for Rapid Bleeding Control in Hospital and Emergency Care Settings

A Prospective Observational Clinical Study Evaluating the Effectiveness and Usability of AYUSH-Approved Hemoflavin Gel for Rapid Hemorrhage Control in OPD, IPD, Procedural, and Emergency/Trauma Care Settings

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/110920
Enrollment
120
Registered
2026-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R58- Hemorrhage, not elsewhere classified

Interventions

Intervention1: Nil: Nil

Sponsors

Yoshivam Pharma LLP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants of all age groups and both genders will be included 2.Patients presenting with external bleeding due to trauma, injuries, or minor procedures 3.Patients with external bleeding ranging from mild to severe intensity, including trauma-related bleeding 4.Patients managed in OPD, IPD, procedural, or emergency/trauma settings 5.Patients or legally acceptable representatives who provide informed consent

Exclusion criteria

Exclusion criteria: 1.Patients with internal bleeding or requiring immediate surgical intervention 2.Known hypersensitivity/allergy to any component of the product

Design outcomes

Primary

MeasureTime frame
Proportion of patients achieving effective bleeding control within 5 minutes of Hemoflavin Gel application across different bleeding severity categories.Timepoint: Proportion of patients achieving effective bleeding control within 5 minutes of Hemoflavin Gel application across different bleeding severity categories.

Secondary

MeasureTime frame
Time to bleeding control (in minutes), including analysis stratified by bleeding severity Estimated reduction in blood loss, as assessed by the treating clinician Proportion of patients (including those with severe bleeding) achieving bleeding control without escalation to advanced interventions Requirement for additional interventions, including suturing, pressure dressing, cauterization, surgical management, or transfusion Clinical stabilization at initial point of care, as assessed by the treating clinician Survival status at hospital admission in patients presenting with moderate to severe bleeding Ease of use, as assessed by healthcare personnel using a predefined rating scale Incidence of adverse events (local and/or systemic) Timepoint: Time to bleeding control(in minutes)

Countries

India

Contacts

Public ContactTanvi Patil

Sangvi Multispeciality Hospital

abhijeet.shete01@gmail.com9604180572

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026